Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobactetiaceae in Vietnam

被引:97
|
作者
Cao, V
Lambert, T
Nhu, DQ
Loan, HK
Hoang, NK
Arlet, G
Courvalin, P
机构
[1] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France
[2] Ctr Etud Pharmaceut, Chatenay Malabry, France
[3] Hop Tenon, Serv Bacteriol, UFR St Antoine, F-75970 Paris 20, France
[4] Inst Pasteur Ho Chi Minh Ville, Ho Chi Minh City, Vietnam
关键词
D O I
10.1128/AAC.46.12.3739-3743.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among 730 Escherichia coli, 438 Klebsiella pneumoniae, and 141 Proteus mirabilis isolates obtained between September 2000 and September 2001 in seven hospitals in Ho Chi Minh City, Vietnam, 26.6% were resistant to ceftazidime, 30% were resistant to cefotaxime, 31.5% were resistant to ceftriaxone, 15.9% were resistant to cefoperazone, and 6% were resistant to cefepime. Resistance to imipenem was found in 5.6% of the isolates. In 55 strains producing extended-spectrum beta-lactamases (32 E. coli isolates, 13 K. pneumoniae isolates, and 10 P. mirabilis isolates), structural genes for VEB-1 (25.5%), CTX-M (25.5%), SHV (38.1%), and TEM (76.3%) enzymes were detected alone or in combination. Sequencing of the PCR products obtained from the K. pneumoniae isolates revealed the presence of bla(VEB-1), bla(CTX-M-14), bla(CTX-M-17), bla(SHV-2), and bla(TEM.1). Molecular typing of the strains with a similar resistance phenotype to broad-spectrum cephalosporins indicated polyclonal spread. ISEcp1 was presumably responsible for dissemination of the bla(CTX-M-like) gene.
引用
收藏
页码:3739 / 3743
页数:5
相关论文
共 50 条
  • [21] Plasmid-encoded gene duplications of extended-spectrum β-lactamases in clinical bacterial isolates
    Sobkowiak, Annika
    Scherff, Natalie
    Schuler, Franziska
    Bletz, Stefan
    Mellmann, Alexander
    Schwierzeck, Vera
    van Almsick, Vincent
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [22] SARI:: Distribution of extended-spectrum β-lactamases in German ICUs
    Jonas, D
    Meyer, E
    Schwab, F
    Rüden, H
    Daschner, F
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 92 - 92
  • [23] Minor extended-spectrum β-lactamases
    Naas, T.
    Poirel, L.
    Nordmann, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 42 - 52
  • [24] Extended-spectrum β-lactamases and clinical outcomes:: Current data
    Ramphal, R
    Ambrose, PG
    CLINICAL INFECTIOUS DISEASES, 2006, 42 : S164 - S172
  • [25] Extended-spectrum β-lactamases in ambulatory care:: a clinical perspective
    Rodriguez-Bano, J.
    Ngugro, M. D.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 104 - 110
  • [26] Clinical significance of extended-spectrum beta-lactamases
    Pujol, M
    Peña, C
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (02): : 69 - 71
  • [27] Minor extended-spectrum β-lactamases
    Akinci, Esragul
    Vahaboglu, Haluk
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (11) : 1251 - 1258
  • [28] Extended-spectrum β-Lactamases: Implications for the Clinical Laboratory and Therapy
    Harada, Sohei
    Ishii, Yoshikazu
    Yamaguchi, Keizo
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (06): : 401 - 412
  • [29] A simple disc diffusion method for detecting AmpC and extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae
    Derbyshire, Helen
    Kay, Gemma
    Evans, Katie
    Vaughan, Carmel
    Kavuri, Umadevi
    Winstanley, Trevor
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) : 497 - 501
  • [30] Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
    Jacoby, GA
    Han, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 908 - 911